Loss of polarity protein Par3 in the intestinal epithelium promotes colitis‐associated colorectal cancer progression by damaging tight junction assembly
Molecular Carcinogenesis · 2023
DOI: 10.1002/mc.23630 ↗At a glance
Journal article in Molecular Carcinogenesis, 2023. Written by Binbin Luo and 5 co-authors. Institution: School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, China. Major MEDLINE topics: Colitis, Colitis-Associated Neoplasms. Cited 8 times so far (Crossref); 38 references. Funded by: Key Project Foundation of Natural Science Research at University of Anhui Province, China, Research Fund Project of Hefei Second People's Hospital, Talent Support Program of Anhui University of Chinese Medicine.
Abstract (original language)
Partitioning defective 3 (Par3) is a polarity protein critical in establishing epithelial cell polarity and tight junctions (TJs). Impaired intestinal epithelial barrier integrity is closely associated with colitis‐associated colorectal cancer (CRC) progression. According to the GEO and TCGA database analyses, we first observed that the expression of Par3 was reduced in CRC patients. To understand how Par3 is related to CRC, we investigated the role of Par3 in the development of CRC using an in vivo genetic approach. Our results show that the intestinal epithelium‐specific PAR3 deletion mice demonstrated a more severe CRC phenotype in the context of azoxymethane/dextran sodium sulfate (AOM/DSS) treatment, with a corresponding increase in tumor number and inflammatory cytokines profile. Mechanistically, loss of Par3 disrupts the TJs of the intestinal epithelium and increases mucosal barrier permeability. The interaction of Par3 with ZO‐1 prevents intramolecular interactions within ZO‐1 protein and facilitates the binding of occludin to ZO‐1, hence preserving TJs integrity. Our results suggest that Par3 deficiency permits pathogenic bacteria and their endotoxins to penetrate the intestinal submucosa and activate TLR4/MyD88/NF‐κB signaling, promoting inflammation‐driven CRC development and that Par3 may be a novel potential molecular marker for the diagnosis of early‐stage CRC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, China.
- Department of Science and Education, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, China.
- Institute of Integrated Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, Anhui, China.
ORCID profiles: Shenyi Wang
Funding
- Key Project Foundation of Natural Science Research at University of Anhui Province, China
- Research Fund Project of Hefei Second People's Hospital
- Talent Support Program of Anhui University of Chinese Medicine
- National Natural Science Foundation of China
Cite
APA
Luo, B., Song, L., Chen, L., Cai, Y., Zhang, M., & Wang, S. (2023). Loss of polarity protein Par3 in the intestinal epithelium promotes colitis‐associated colorectal cancer progression by damaging tight junction assembly. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23630
Vancouver
Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S. Loss of polarity protein Par3 in the intestinal epithelium promotes colitis‐associated colorectal cancer progression by damaging tight junction assembly. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23630
BibTeX
@article{Luo2023,
author = {Luo, Binbin and Song, Linyi and Chen, Limiao and Cai, Yue and Zhang, Mingwei and Wang, Shenyi},
title = {Loss of polarity protein Par3 in the intestinal epithelium promotes colitis‐associated colorectal cancer progression by damaging tight junction assembly},
journal = {Molecular Carcinogenesis},
year = {2023},
doi = {10.1002/mc.23630}
}
EUVIMED